Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trialMin Yan, Huajun Li, Limin Niu et al.|Nature Communications|2023Cited by 14
Efficacy and safety of HER2-ADC SHR-A1811 in HER2-positive breast cancer with brain metastases.Min Yan, Ruoyu Huang, Huimin Lv et al.|Journal of Clinical Oncology|2024Cited by 5